BR9910201A - Sistema terapêutico transdérmico para emprego de candesartan - Google Patents

Sistema terapêutico transdérmico para emprego de candesartan

Info

Publication number
BR9910201A
BR9910201A BR9910201-3A BR9910201A BR9910201A BR 9910201 A BR9910201 A BR 9910201A BR 9910201 A BR9910201 A BR 9910201A BR 9910201 A BR9910201 A BR 9910201A
Authority
BR
Brazil
Prior art keywords
candesartan
therapeutic system
transdermal therapeutic
transdermal
employment
Prior art date
Application number
BR9910201-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Thomas Struengmann
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of BR9910201A publication Critical patent/BR9910201A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9910201-3A 1998-05-06 1999-05-04 Sistema terapêutico transdérmico para emprego de candesartan BR9910201A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19820151A DE19820151A1 (de) 1998-05-06 1998-05-06 Transdermales therapeutisches System zur Anwendung von Candesartan
PCT/EP1999/003029 WO1999056734A2 (de) 1998-05-06 1999-05-04 Transdermales therapeutisches system zur anwendung von candesartan

Publications (1)

Publication Number Publication Date
BR9910201A true BR9910201A (pt) 2001-01-09

Family

ID=7866803

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910201-3A BR9910201A (pt) 1998-05-06 1999-05-04 Sistema terapêutico transdérmico para emprego de candesartan

Country Status (8)

Country Link
EP (1) EP1085858B1 (enExample)
JP (1) JP4659982B2 (enExample)
AT (1) ATE280575T1 (enExample)
AU (1) AU760550B2 (enExample)
BR (1) BR9910201A (enExample)
CA (1) CA2331414C (enExample)
DE (2) DE19820151A1 (enExample)
WO (1) WO1999056734A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60045211D1 (de) 1999-02-19 2010-12-23 Takeda Pharmaceutical Präparationen zur perkutanen aufnahme von zusammnesetzungen die einen angiotensin-ii-rezeptorantagonismus aufweisen
EG24716A (en) * 2002-05-17 2010-06-07 Novartis Ag Combination of organic compounds
WO2005070463A2 (en) * 2004-01-12 2005-08-04 Sepracor, Inc. Compositions comprising (s)-amlodipine malate and an angiotensin receptor blocker and methods of their use
EP1711168A2 (en) * 2004-01-23 2006-10-18 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of candesartan cilexetil
EP1997479A1 (en) * 2007-05-31 2008-12-03 Helm AG Stabilized amorphous candesartan cilexetil compositions for oral administration
JP5308788B2 (ja) * 2008-11-27 2013-10-09 興和株式会社 貼付剤
CA2766120C (en) * 2009-07-07 2018-08-14 Convatec Technologies Inc. Amphiphilic silicone copolymers for pressure sensitive adhesive applications
CN104356116A (zh) * 2014-10-17 2015-02-18 北京理工大学 坎地沙坦有机胺盐及氨盐的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674618A5 (enExample) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US4898732A (en) * 1988-05-04 1990-02-06 The Clinipad Corporation Inhibiting of tumor growth with an antagonist of the renin-angioten-sin system
DE58906975D1 (de) * 1988-08-02 1994-03-24 Ciba Geigy Mehrschichtiges Pflaster.
ATE107517T1 (de) * 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd Transdermales therapeutisches mittel.
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
GB2256135B (en) * 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
CA2115985A1 (en) * 1993-02-25 1994-08-26 Kohei Nishikawa Vascular hypertrophy suppressor
DE4341444C2 (de) * 1993-12-04 1996-03-14 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung
DE19512181C2 (de) * 1995-03-31 2003-11-06 Hexal Pharma Gmbh Transdermales System mit Ramipril und/oder Trandolapril als ACE-Hemmer
JPH08310946A (ja) * 1995-05-19 1996-11-26 Yuutoku Yakuhin Kogyo Kk 経皮吸収製剤
FR2735365B1 (fr) * 1995-06-14 1997-09-05 Sanofi Sa Utilisation d'un antagoniste de l'angiotensine ii et d'un derive du benzofurane pour la preparation d'un medicament utile dans le traitement des affections cardiovasculaires
FR2746013B1 (fr) * 1996-03-18 1998-05-29 Sanofi Sa Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus
JP4346696B2 (ja) * 1996-05-28 2009-10-21 久光製薬株式会社 経皮治療用装置
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid
JPH11315034A (ja) * 1998-03-04 1999-11-16 Takeda Chem Ind Ltd アンギオテンシンｉｉ拮抗作用を有する化合物の徐放性製剤、その製造法および用途

Also Published As

Publication number Publication date
EP1085858B1 (de) 2004-10-27
WO1999056734A3 (de) 2000-01-27
WO1999056734A2 (de) 1999-11-11
EP1085858A2 (de) 2001-03-28
DE59910944D1 (de) 2004-12-02
DE19820151A1 (de) 1999-11-11
CA2331414C (en) 2008-09-16
JP4659982B2 (ja) 2011-03-30
JP2002513753A (ja) 2002-05-14
AU3931199A (en) 1999-11-23
AU760550B2 (en) 2003-05-15
ATE280575T1 (de) 2004-11-15
CA2331414A1 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
BR9712806A (pt) Emplastro de matriz adesiva sensìvel à pressão para liberação transdérmica de sais de agentes farmacêuticos
IT1283102B1 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
DK0766664T3 (da) Metalloproteinaseinhibitorer
BR0012082A (pt) Formulação farmacêutica para administração compreendendo morfina e seu uso
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
TR199901417T2 (xx) Analjezik etkisi olan yeni bile�imler.
TR200402579T4 (tr) Kristalin monohidrat, bunun imalat yöntemi ve bir ilaç maddesinin imalatında kullanımı
PT1126830E (pt) Preparações farmacêuticas para uso externo contendo agentes anti-inflamatórios e analgésicos não esteróides
BR9811458A (pt) "sistema solvente para penetração melhorada de compostos farmacêuticos"
YU2494A (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
BR9607872A (pt) Medicamento administrável por via transdérmica com inibidores de ace.
BR9913135A (pt) Formulação oral
BR0111892A (pt) Bis-arilsulfonas
DK0710108T3 (da) Flydende, farmaceutisk præparat til oral anvendelse indeholdende 2-(4-isobutylphenyl)-propionsyre
BR9910201A (pt) Sistema terapêutico transdérmico para emprego de candesartan
DE59914183D1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
BR0007686A (pt) Uso de antagonistas receptores da angiotensina ii para tratar enfartação miocárdia aguda
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
ES2176702T3 (es) Antimicoticos con alta liberacion de sustancia activa.
GT199900171A (es) Concentrado oral de sertralina.
ATE259638T1 (de) Nicht-festes topisch anzuwendendes arzneimittel enthaltend glyzerol und alchemilla vulgaris extrakt
BR9707770C1 (pt) Tifluzamida com eficácia aperfeiçoada
BR0002772A (pt) Uso de ligantes melatoninérgicos na obtenção de composições farmacêuticas pretendidas para a prevenção ou o tratamento de patologias do sistema gastrintestinal
DE50010973D1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 9/70, A61K 31/4184, A61K 9/00, C07D 235/04

Ipc: A61K 9/70 (2009.01), A61K 31/4184 (2009.01), A61K

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO DE PATENTE, UMA VEZ QUE A MATERIA PLEITEADA NAO APRESENTA ATIVIDADE INVENTIVA ( ART. 8O E 13 DA LPI ), O RELATORIO NAO DESCREVE DE FORMA CLARA E SUFICIENTEMENTE O OBJETO, DE MODO A POSSIBILITAR A SUA REALIZACAO POR TECNICO NO ASSUNTO ( ART. 24 DA LPI ), AS REIVINDICACOES NAO DEFINEM, DE MODO CLARO E PRECISO, A METERIA OBJETO DE PROTECAO ( ART. 25 DA LPI )

B12B Appeal against refusal [chapter 12.2 patent gazette]